NAVARRE CHRISTOPHE 4/A
4/A · AVADEL PHARMACEUTICALS PLC · Filed Mar 2, 2018
Insider Transaction Report
Form 4/AAmended
NAVARRE CHRISTOPHE
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-28$10.51/sh+35,000$367,850→ 35,000 totalExercise: $10.51From: 2018-06-28Exp: 2022-06-28→ ADSs (35,000 underlying)
Footnotes (2)
- [F1]Options become exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.